Finding Needles in a Haystack: A Methodology for Identifying and Sampling Community-Based Youth Smoking Cessation Programs

2010 ◽  
Vol 34 (1) ◽  
pp. 35-51 ◽  
Author(s):  
Sherry Emery ◽  
Jungwha Lee ◽  
Susan J. Curry ◽  
Tim Johnson ◽  
Amy K. Sporer ◽  
...  
2016 ◽  
Vol 17 (6) ◽  
pp. 845-852 ◽  
Author(s):  
Susan J. Curry ◽  
Robin J. Mermelstein ◽  
Amy K. Sporer

A national survey of 591 community-based youth smoking cessation programs provided an opportunity to assess the sustainability of health promotion programming over a 3-year period. Initial survey questions were mapped to five sustainability domains (local ownership, organizational alignment, resources, demand, and standard operating procedures) and examined to identify correlates of sustained operation. Follow-up surveys were completed with 305 programs. Assuming loss to follow-up indicated failure to sustain, the overall rate of program continuation was 32%. Baseline correlates of sustaining operation included the following: serving more youth, training staff in smoking cessation, longer time in operation at the initial survey, and receiving state funding as a sole source of support. Primary reasons for discontinuation related to lack of funding, insufficient enrollment, change of focus from tobacco cessation, and scheduling difficulty. Replication of studies like this survey of youth smoking cessation programs with other types of health promotion and public health programming can further test sustainability frameworks, provide validated measures, and ultimately inform a robust and replicable array of lasting, effective, evidence-based public health programs.


Author(s):  
Francisco Cartujano-Barrera ◽  
Michelle Lee D’Abundo ◽  
Evelyn Arana-Chicas ◽  
Surina Chock ◽  
Pamela Valera ◽  
...  

The purpose of this study was to identify the perspectives from key leaders of community-based organizations (CBOs) and clinics serving people living with HIV on barriers and facilitators of smoking cessation among Latino smokers living with HIV. Semi-structured interviews were conducted in English and Spanish with 10 key leaders. Using a social ecological model, qualitative theoretical analysis was used to analyze the results. Participants identified barriers at the individual (e.g., low education level, HIV, and financial stress), interpersonal (e.g., language barriers, low social support), organizational (e.g., lack of smoking cessation resources and targeted interventions), community (e.g., HIV and mental health stigma), and policy (e.g., paperwork for insurance) level. Participants identified facilitators at the individual (e.g., high participation in trials, good medication adherence), interpersonal (e.g., no smoking in social circles), organizational (e.g., bilingual staff, culturally competent care), community (e.g., providing transportation, the coronavirus disease 2019 as an opportunity for smoking cessation), and policy level (e.g., existence of funding, comprehensive insurance programs). These results provide operational strategies to address smoking disparities among Latino smokers living with HIV. Further research is needed on how to integrate these perspectives into effective smoking cessation interventions.


2008 ◽  
Vol 10 (5) ◽  
pp. e49 ◽  
Author(s):  
Robyn Whittaker ◽  
Ralph Maddison ◽  
Hayden McRobbie ◽  
Chris Bullen ◽  
Simon Denny ◽  
...  

2013 ◽  
Author(s):  
Gary A. Giovino ◽  
Dianne C. Barker

2007 ◽  
pp. 239-247
Author(s):  
Chris Lovato ◽  
Gayla Swihart ◽  
Jean Shoveller

2019 ◽  
Vol 5 (1) ◽  
Author(s):  
Catherine Hayes ◽  
Aurelia Ciblis ◽  
Catherine Darker ◽  
Nadine Dougall ◽  
Joanne Vance ◽  
...  

Abstract Background Tobacco use is the leading cause of preventable death in Ireland with almost 6000 smokers dying each year from smoking-related diseases. The ‘We Can Quit2’ (WCQ2) study is a pilot pragmatic two-arm, parallel-group, cluster randomised trial that aims to explore the feasibility and acceptability of trial processes including recruitment and to estimate parameters to inform sample size estimates needed for an effectiveness trial. This future trial will assess the effectiveness of a community-based smoking cessation intervention for women living in disadvantaged areas on short- and medium-term cessation rates. Methods/design Four matched pairs of districts (eight clusters) selected by area level of deprivation, geographical proximity, and eligibility for free medical services will be randomised to receive either WCQ (behavioural support + access to Nicotine Replacement Therapy (NRT)) delivered over 12 weeks by trained Community Facilitators (CFs) or to a form of usual care, a one-to-one smoking cessation service delivered by Smoking Cessation Officers from Ireland’s national health service, the Health Service Executive (HSE). Within each cluster, 24–25 women will be recruited (97 per arm; 194 in total) in 4 phases with consent obtained prior to cluster randomisation. The outcome measures will assess feasibility and acceptability of trial processes, including randomisation. Outcome data for a future definitive intervention (biochemically validated smoking abstinence) will be collected at end of programme (12 weeks) and at 6 months. WCQ2 has an embedded process evaluation using both qualitative and quantitative methods. This will be conducted (semi-structured client and CF interviews, intervention delivery checklist, and diary) to explore acceptability of trial processes, intervention fidelity, trial context, and implementation. Trial processes will be assessed against domains of the PRECIS-2 wheel to inform a future definitive trial design. Discussion Data from this pilot trial will inform the design and sample size for a full cluster randomised trial to determine the effectiveness of an intervention tailored to disadvantaged women in improving smoking cessation rates. It will provide transferable learning on the systems and implementation strategies needed to support effective design of future pragmatic community-based trials which address health promotion interventions for women in disadvantaged communities. Trial registration Concurrent to publication. Controlled trials ISRCTN74721694.


Sign in / Sign up

Export Citation Format

Share Document